Prospective Cohort of Locally Advanced and Metastatic Non-Small Cell Lung Cancer Patients With Activating EGFR Mutations
Clinical trial NCT05103605 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05103605
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-12
- Primary completion
- 2026-01-15
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.